Nonreporting of cannabis use: Predictors and relationship to treatment outcome in methadone maintained patients

Addictive Behaviors

Volumn 32, Issue 5, 2007, Pages 938-949

  Ghitza, Udi E ^a   Epstein, David H ^a   Preston, Kenzie L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cocaine; Heroin; Marijuana; Self Report; Substance Use; THC

Indexed keywords

CANNABIS; COCAINE; DIAMORPHINE; METHADONE;

ADULT; AFRICAN AMERICAN; ARTICLE; BEHAVIOR THERAPY; CANNABIS ADDICTION; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PSYCHOPATHY; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; URINALYSIS;

ADMINISTRATION, ORAL; ADULT; AFRICAN AMERICANS; ANALGESICS, OPIOID; BEHAVIOR THERAPY; COCAINE; COCAINE-RELATED DISORDERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; METHADONE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; SEX DISTRIBUTION; SUBSTANCE ABUSE DETECTION; TETRAHYDROCANNABINOL; TIME FACTORS; TOKEN ECONOMY; TREATMENT OUTCOME;

EID: 33847202193     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2006.06.034     Document Type: Article

References (30)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. (4th ed.). (1994), American Psychological Association, Washington, DC
2. Buchan B.J., Dennis M., Tims F.M., and Diamond G.S. Cannabis use: Consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction 97 (2002) S1:98-S1:108
3. Collins K.S., Hughes D.L., Doty M.M., Ives B.L., Edwards J.N., and Tenney K. Diverse communities, common concerns: Assessing health care quality for minority Americans (2002), The Commonwealth Fund, New York, NY. http://www.cmwf.org.
4. Cooper-Patrick L., Gallo J.J., Gonzalez J.J., Vu H.T., Powe N.R., Nelson C., et al. Race, gender, and partnership in the patient-physician relationship. Journal of the American Medical Association 282 (1999) 583-589
5. Dascalu M., Compton W.M., Horton J.C., and Cottler L.B. Validity of DIS IV in diagnosis depression and other psychiatric disorders among substance users. Drug and Alcohol Dependence 63 (2001) S37
6. Derogatis L.R. SCL-90-R administration, scoring and procedures manual- II for the revised version (1977), Clinical Psychometric Research, Towson, MD
7. Digiusto E., Seres V., Bibby A., and Batey R. Concordance between urinalysis results and self-reported drug use by applicants for methadone maintenance in Australia. Addictive Behaviors 21 (1996) 319-329
8. Epstein D.H., Hawkins W.E., Covi L., Umbricht A., and Preston K.L. Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychology of Addictive Behaviors 17 (2003) 73-82
9. Epstein D.H., and Preston K.L. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against. Addiction 98 (2003) 269-279
10. Fendrich M., and Johnson T.P. Race/ethnicity differences in the validity of self-reported drug use: results from a household survey. Journal of Urban Health 2 S3 (2005) iii67-iii81
11. Fendrich M., and Mackesy-Amiti M.E. Inconsistencies in lifetime cocaine and marijuana use reports: Impact on prevalence and incidence. Addiction 90 (1995) 111-118
12. Ferrara S.D., Tedeschi L., Frison G., Bruscini G., Castagna F., Bernardelli B., et al. Drugs-of-abuse testing in urine: Statistical approach and experimental comparisons of immunochemical and chromatographic techniques. Journal of Analytical Toxicology 18 (1994) 278-291
13. Fishbain D.A., Cutler R.B., Rosomoff H.L., and Rosomoff R.S. Validity of self-reported drug use in chronic pain patients. Clinical Journal of Pain 15 (1999) 184-191
14. Harrison E.R., Haaga J., and Richards T. Self-reported drug use data: What do they reveal?. American Journal of Drug and Alcohol Abuse 19 (1993) 423-441
15. Hosmer D.W., and Lemeshow S. Applied logistic regression (1989), Wiley, New York
16. Huestis M.A., Mitchell J.M., and Cone E.J. Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results. Clinical Chemistry 40 (1994) 729-733
17. King V.L., Kidorf M.S., Stoller K.B., Carter J.A., and Brooner R.K. Influence of antisocial personality subtypes on drug abuse treatment response. Journal of Nervous and Mental Disease 189 (2001) 593-601
18. Little R.E., Uhl C.N., Labbe R.F., Abkowitz J.L., and Phillips E.L.R. Agreement between laboratory tests and self-reports of alcohol, tobacco, caffeine, marijuana, and other drug use in post-partum women. Social Science & Medicine 22 (1986) 91-98
19. McLellan A.T., Luborsky L., Cacciola J., Griffith J., Evans F., Barr H.L., et al. New data from the Addiction Severity Index: Reliability and validity in three centers. Journal of Nervous and Mental Disease 173 (1985) 412-423
20. Neale J., and Robertson M. Comparison of self-report data and oral fluid testing in detecting drug use amongst new treatment clients. Drug and Alcohol Dependence 71 (2003) 57-64
21. Niedbala S.R., Kardos K.W., Fritch D.F., Kunsman K.P., Blum K.A., Newland G.A., et al. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. Journal of Analytical Toxicology 29 (2005) 1-9
22. Poythress N.G., Edens J.F., and Lilienfeld S.O. Criterion-related validity of the Psychopathic Personality Inventory in a prison sample. Psychological Assessment 10 (1998) 426-430
23. Preston K.L., Silverman K., Higgins S.T., Brooner R.K., Montoya I., Schuster C.R., et al. Cocaine use early in treatment predicts outcome in a behavioral treatment program. Journal of Consulting and Clinical Psychology 66 (1998) 691-696
24. Preston K.L., Umbricht A., and Epstein D.H. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Archives of General Psychiatry 57 (2000) 395-404
25. Preston K.L., Umbricht A., Wong C.J., and Epstein D.H. Shaping cocaine abstinence by successive approximation. Journal of Consulting and Clinical Psychology 69 (2001) 643-654
26. Richardson J., Fendrich M., and Johnson T.P. Neighborhood effects on drug reporting. Addiction 12 (2003) 1705-1711
27. Seto M.C., Khattar N.A., Lalumière M.L., and Quinsey V.L. Deception and sexual strategy in psychopathy. Personality and Individual Differences 22 (1997) 301-307
28. Tassiopoulous K., Bernstein J., Heeren T., Levenson S., Hingson R., and Bernstein E. Predictors of disclosure of continued cocaine use. Addictive Behaviors 31 (2006) 80-89
29. Zachary R.A. Shipley institute of living scale, revised manual (1986), Western Psychological Services, Los Angeles, CA
30. Zágon I.K., and Jackson H.J. Construct validity of a psychopathy measure. Personality and Individual Differences 17 (1994) 125-135